Monitor for future purchase orders from Israel Railways beyond the initial 15 stations and watch for any exercise of the $1 million investment option, which would dilute BiomX's ownership in Zorronet. The lack of minimum purchase obligations and termination clause limit near-term revenue visibility.
Price Chart
Executive Summary
BiomX subsidiary Zorronet secured a framework supply agreement with Israel Railways to deploy AI-powered animal detection and deterrence systems following a successful pilot that achieved 98% effectiveness. The agreement covers maintenance of 15 existing stations with potential for expansion, but includes no minimum purchase obligations and allows Israel Railways to terminate with 30 days' notice. Israel Railways also holds an unexercised option to invest $1 million for a 20% stake in Zorronet.
Key Facts
- Zorronet (BiomX subsidiary) entered into a framework supply agreement with Israel Railways for AI-powered animal detection and deterrence systems
- Agreement follows a successful pilot that achieved 98% success rate in keeping animals off railway tracks
- Initial phase covers maintenance of 15 existing alert stations with potential for additional orders at Israel Railways' discretion
- Israel Railways has unexercised option to invest $1 million for 20% of Zorronet
- Agreement has 12-month initial term with Israel Railways holding sole option to extend for another 12 months
- Israel Railways can terminate agreement for any reason with 30 days' notice
Financial Impact
Pilot investment of approximately $266,000; no specific contract value disclosed for the framework agreement
Risk Factors
- No minimum purchase obligations beyond existing 15 stations
- Israel Railways can terminate agreement with 30 days' notice
- Potential dilution of BiomX's ownership in Zorronet if investment option is exercised
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-044722 |
| Document: ea028664701ex99-1_biomx.htm | 0001213900-26-044722 |
| Document: 0001213900-26-044722-index-headers.html | 0001213900-26-044722 |
| Document: 0001213900-26-044722-index.html | 0001213900-26-044722 |
| Document: 0001213900-26-044722.txt | 0001213900-26-044722 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | 8-K | $0.1425 $1.85 | ▲ +1198.25% | ▲ +1199.20% | $0.3600 (+152.63%) |
Aug 28, 2026 5w ago | 8-K | $0.1371 $0.1550 | ▲ +13.06% | ▲ +13.20% | $0.3600 (+162.58%) |
Aug 5, 2026 8w ago | Press Release | $0.1800 $0.1483 | ▲ +17.61% | ▲ +17.96% | $0.3600 (−100.00%) |
Jul 28, 2026 9w ago | 8-K | $0.1834 $0.1868 | ▼ −1.85% | ▲ +0.42% | $0.3600 (−96.29%) |
Jul 28, 2026 9w ago | Press Release | $0.1834 $0.1868 | ▼ −1.85% | ▲ +0.42% | $0.3600 (−96.29%) |
Jul 27, 2026 9w ago | 424B5 | $0.1834 $0.1868 | ▼ −1.85% | ▲ +0.42% | $0.3600 (−96.29%) |
Jul 8, 2026 12w ago | Press Release | $0.2758 $0.2100 | ▼ −23.86% | ▼ −24.72% | $0.3600 (+30.53%) |
Jul 2, 2026 13w ago | 8-K | $0.3190 $0.2800 | ▲ +12.23% | ▲ +13.16% | $0.3600 (−12.85%) |
Jun 29, 2026 13w ago | S-1 | $0.3478 $0.3020 | ▲ +13.17% | ▲ +13.77% | $0.3600 (−3.51%) |
Jun 22, 2026 14w ago | DEFA14A | $0.4615 $0.3590 | ▼ −22.21% | ▼ −23.22% | $0.3600 (−21.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access